New frontiers in psoriasis: evolving
treatment goals, patient expectations
and therapeutic targets
Friday, March 20, 2020
7:00 p.m. – 8:20 p.m.
Cripple Creek Ballroom
Embassy Suites Denver
Downtown Convention Center
Please join us for an educational
symposium discussing new frontiers in
- Evolving expectations in the treatment of psoriasis
- How to measure the success of treatment for the patient
- Expert insights on the IL-17 family, and why these
cytokines may be essential to addressing the
complexities of the disease.
This program is independent and is not part of the official AAD Annual Meeting
as planned by its Scientific Assembly Committee.
This program does not qualify for Continuing Medical Education (CME) Credit.Pre-register Now
Address the burden of psoriasis that patients continue to experience, despite advances in treatment
Cut through the complex pathophysiology of psoriasis to the fundamental role of members of key inflammatory cytokines
Examine why PASI scores may not be enough to measure outcomes in psoriasis, when considering patients' needs and expectations
Kenneth B. Gordon, MD (Chair)
Department of Dermatology, Medical College of Wisconsin, Milwaukee, WI, USA
Kenneth Gordon is Thomas J Russell Family/Milwaukee Community Dermatologists Professor and Chair of Dermatology at the Medical College of Wisconsin, Milwaukee.
Previously Dr Gordon served as Professor of Dermatology at Northwestern University, Feinberg School of Medicine (Chicago) and Associate Director, Center for Clinical Research of Northwestern University Center for Clinical and Translational Science.
Dr Gordon received his medical degree from Columbia University, New York. In his position as a member of the American Academy of Dermatology (AAD), Dr Gordon has chaired several sessions at the annual meeting, and is on the Working Group on Psoriasis and Psoriatic Arthritis.
Dr Gordon has published widely in several journals including Journal of the American Academy of Dermatology and The Lancet, and he is a reviewer for others, such as British Journal of Dermatology and The New England Journal of Medicine. His main research interests are therapies for psoriasis and psoriatic arthritis, and he contributed to the development of the AAD treatment guidelines for these diseases.
Prof. Kristian Reich, MD, PhD (equivalent)
University Clinic Hamburg-Eppendorf, Skinflammation®, Hamburg, and Dermatologikum Berlin, Germany
Prof. Dr. med. Kristian Reich, born 1965, is Professor for Translational Research in Inflammatory Skin Diseases at the Institute for Health Services Research in Dermatology and Nursing, University Clinic Hamburg-Eppendorf. He is founder and medical director of Skinflammation, Hamburg, a center specialized in clinical research, patient care and medical education. Since 2013 he is also partner at the Dermatologikum Berlin.
Reich finished his doctoral thesis in mucosal immunology with summa cum laude 1995 in Munich and his Habilitation (PhD equivalent) in skin immunology following his final exam as consultant dermatologist in Göttingen. In 2003 he was appointed University Professor and Vice Director of the Dermatology Department at the Georg-August-Universität Göttingen.
His main research interests include genetic and immunologic mechanisms of cutaneous inflammatory disorders and cancer and the development of new therapies for skin diseases such as psoriasis and atopic dermatitis. He published more than 300 articles in international peer-reviewed journals, including The Lancet, the New England Journal of Medicine, the Journal of Immunology and the Journal of Allergy and Clinical Immunology. Prof. Reich chairs the scientific committee of the German Psoriasis Registry PsoBest, is member of the board of the ProDerma and the Alfred-Marchionini foundation. He is counselor of the International Psoriasis Council and the International Eczema Council.
Prof. Reich received numerous prices and rewards including the Herbert-Herxheimer Research Price of the German Society for Immunology and Allergology (2003), the R.K. Schachter Lectureship (2012), and the Stars of the Academy Award of the American Academy of Dermatology (2016).
Kristina Callis Duffin, MD, MS
Associate Professor and Co-Chair, Department of Dermatology University of Utah Salt Lake City, Utah
Kristina Callis Duffin, MD, MS is Associate Professor and Co-Chair of the Department of Dermatology at the University of Utah. Dr. Callis Duffin is a graduate of the University of Washington School of Medicine, and completed residencies in internal medicine then in dermatology at the University of Utah. Her clinical and research focus is the management of patients with psoriasis. She has participated in over 50 clinical trials for new psoriasis therapies. She has served over 6 years on the Medical Board of the National Psoriasis Foundation. Dr. Callis Duffin has authored or co-authored over 60 peer-reviewed articles, reviews or book chapters on psoriasis. Since 2002, she has been teaching investigators on clinical trial measures such as PASI, and partnered with Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) to develop standardized online training modules for psoriasis and psoriatic arthritis measures. She is the current president of GRAPPA (Group for Research and Assessment of Psoriasis and Psoriatic Arthritis), and was a founding member of IDEOM, the International Dermatology Outcomes Measures initiative.